West Family Investments Inc. Has $524,000 Stock Holdings in Cigna Group $CI

West Family Investments Inc. boosted its stake in shares of Cigna Group (NYSE:CI) by 38.2% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,586 shares of the health services provider’s stock after purchasing an additional 438 shares during the period. West Family Investments Inc.’s holdings in Cigna Group were worth $524,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Valeo Financial Advisors LLC boosted its holdings in Cigna Group by 86,071.1% in the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after purchasing an additional 3,471,249 shares in the last quarter. Norges Bank bought a new stake in shares of Cigna Group in the 2nd quarter worth approximately $1,110,426,000. Nuveen LLC acquired a new stake in shares of Cigna Group during the 1st quarter valued at about $727,905,000. Price T Rowe Associates Inc. MD grew its position in Cigna Group by 10.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after acquiring an additional 1,094,327 shares during the period. Finally, GQG Partners LLC boosted its position in Cigna Group by 21.5% in the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after buying an additional 865,092 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Stock Performance

Shares of CI opened at $277.28 on Friday. The firm has a market cap of $74.07 billion, a P/E ratio of 15.14, a PEG ratio of 0.88 and a beta of 0.44. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The firm’s 50 day moving average price is $284.99 and its two-hundred day moving average price is $297.30.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.64 by $0.19. The firm had revenue of $69.57 billion for the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter last year, the business posted $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be issued a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s dividend payout ratio is presently 26.64%.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Wells Fargo & Company decreased their price target on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a research report on Wednesday, November 5th. Sanford C. Bernstein lowered their price objective on shares of Cigna Group from $346.00 to $294.00 and set a “market perform” rating for the company in a research report on Wednesday, November 12th. TD Cowen reduced their price objective on Cigna Group from $387.00 to $333.00 and set a “buy” rating on the stock in a report on Tuesday, November 4th. JPMorgan Chase & Co. cut their price target on Cigna Group from $428.00 to $375.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 4th. Finally, Leerink Partners lowered their target price on shares of Cigna Group from $300.00 to $270.00 in a report on Friday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and a consensus target price of $334.05.

Insider Activity

In other Cigna Group news, CEO David Cordani purchased 4,134 shares of the stock in a transaction on Monday, November 3rd. The shares were purchased at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the transaction, the chief executive officer directly owned 157,935 shares in the company, valued at $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.70% of the company’s stock.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.